Lakritz J et al. |
Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. |
1999 |
Am. J. Vet. Res. |
pmid:10211682
|
McConnell SA and Amsden GW |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. |
1999 |
Pharmacotherapy |
pmid:10212011
|
Betriu C et al. |
Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10212752
|
Dubois J and St-Pierre C |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10212753
|
Biedenbach DJ et al. |
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10212755
|
Kim RB et al. |
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. |
1999 |
Pharm. Res. |
pmid:10213372
|
Torii A |
[Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)]. |
1999 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:10214084
|
Bercault N and Linassier P |
[The value of sepsis isolation to diminish the spread of multidrug-resistant bacteria in intensive care. Consequences on the incidence of nosocomial infections]. |
1999 |
Rev Med Interne |
pmid:10220829
|
Perez-Trallero E et al. |
Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. |
1999 Mar-Apr |
Emerging Infect. Dis. |
pmid:10221875
|
Jackson LA et al. |
Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. |
1999 Mar-Apr |
Emerging Infect. Dis. |
pmid:10221884
|